Clinical Trials Directory

Trials / Completed

CompletedNCT02040545

Salivary Diagnostic Testing for IVF

Venopuncture-Free IVF: Can "Patient-friendly" Salivary Hormone Measurements Replace Serum Monitoring of IVF Patients?

Status
Completed
Phase
Study type
Observational
Enrollment
335 (actual)
Sponsor
Boston IVF · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.

Detailed description

The goal of this study is to determine the performance of a salivary hormone competitive immunoassay for monitoring patient estrogen and progesterone levels during treatment for infertility using controlled ovarian stimulation (COH) and in vitro fertilization (IVF). Specifically, inter- and intra-assay precision, correlation with serum measurements (the gold-standard), and user satisfaction will be determined. Ultimately, the potential applicability and reliability of salivary steroid monitoring in IVF cycles will be assessed.

Conditions

Timeline

Start date
2010-05-21
Primary completion
2016-05-01
Completion
2017-04-04
First posted
2014-01-20
Last updated
2017-04-14

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02040545. Inclusion in this directory is not an endorsement.

Salivary Diagnostic Testing for IVF (NCT02040545) · Clinical Trials Directory